Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

trilostane MeSH Supplementary Concept Data 2025


MeSH Supplementary
trilostane
Unique ID
C009954
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C009954
Entry Term(s)
4alpha,5-epoxy-17beta-hydroxy-3-oxoandrostane-2-carbonitrile
Modrenal
WIN 24,540
Pharm Action
Abortifacient Agents, Steroidal
Antineoplastic Agents
Enzyme Inhibitors
Registry Numbers
L0FPV48Q5R
0
Related Numbers
13647-35-3
Previous Indexing
*ANDROSTANES (75-80)
*ANDROSTANOLS (80-82)
NITRILES (75-82)
Heading Mapped to
Dihydrotestosterone / analogs & derivatives
Frequency
321
Note
inhibits conversion of pregnenolone to progesterone; adrenal blocking agent used in treatment of Cushing's syndrome
Source
Endocrinology 103(4):1411;1978
Endocrinology 97(1):136;1975
Fertil Steril 1979;32(4):464
J Endocrinol 76:293;1978
Steroids 32(2):257;1978
Indexing Information
Oxidative Phosphorylation Coupling Factors
3-Hydroxysteroid Dehydrogenases
Date of Entry
1975/01/01
Revision Date
2015/09/27
trilostane Preferred
WIN 24,540 Narrower
Modrenal Narrower
page delivered in 0.005s